This Slide: #69 of 83 |
Slide #69. Bio-Rad Laboratories, Inc. — AbD Serotec
Acquirer:
Bio-Rad Laboratories, Inc. (NYSE:BIO)
Acquiree:
AbD Serotec
Details:
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced that it has purchased AbD Serotec, a division of MorphoSys AG, for approximately 53 million euros in cash.
Bio-Rad Laboratories is a manufacturer and distributor of its own life science research and clinical diagnostics products. Co. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. Co. operates in two segments: Life Science, which develops, manufactures and markets a portfolio of various products; and Clinical Diagnostics, which designs, manufactures, markets and supports test systems, informatics systems, test kits and quality controls that serve clinical laboratories in the diagnostics market.
BIO SEC Filing Email Alerts Service
Open the BIO Page at The Online Investor »
|
Open the BIO Page at The Online Investor (in a new window) »
Free BIO Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Strong Buy (3.75 out of 4) 70th percentile
(ranked higher than approx. 70% of all stocks covered)
Analysts' Target Price: BIO Stock Forecast Based on Zacks ABR data; powered by Xignite |